CMND
Clearmind Medicine·NASDAQ
--
--(--)
--
--(--)
CMND Filings
Filing Date
Form Description
Form Type
2026-02-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-03
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-03 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-01-27
Form POS AM - Post-Effective amendments for registration statement
2026-01-27 ·
Form POS AM - Post-Effective amendments for registration statement
2026-01-27
Form POS AM - Post-Effective amendments for registration statement
2026-01-27 ·
Form POS AM - Post-Effective amendments for registration statement
2026-01-27
Form POS AM - Post-Effective amendments for registration statement
2026-01-27 ·
Form POS AM - Post-Effective amendments for registration statement
2026-01-20
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2026-01-20 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
